Aging affects reprogramming of pulmonary capillary endothelial cells after lung injury in male mice

  • 0Université Côte d'Azur, UMR CNRS 7275 Inserm U1323, IPMC, Valbonne, France.

|

|

Summary

This summary is machine-generated.

Aging impairs lung regeneration, altering pulmonary capillary endothelial cells (PCEC) and their response to injury. These age-related changes in PCEC may drive persistent fibrosis in aging lungs.

Area Of Science

  • Pulmonary Medicine
  • Cell Biology
  • Aging Research

Background

  • Aging is a major risk factor for fibrotic diseases, characterized by impaired tissue regeneration.
  • Fibrotic diseases, such as idiopathic pulmonary fibrosis, significantly impact lung function and patient outcomes.

Purpose Of The Study

  • To investigate the impact of aging on lung regeneration following bleomycin-induced injury.
  • To compare the transcriptomic profiles of pulmonary capillary endothelial cells (PCEC) in young versus aged mice during fibrosis resolution.
  • To identify age-associated molecular alterations in PCEC that may contribute to persistent lung fibrosis.

Main Methods

  • Longitudinal single-cell RNA sequencing and spatial transcriptomics were employed.
  • Transcriptomic analysis was performed on bleomycin-induced fibrotic lungs from young and aged male mice at three distinct time points (peak fibrosis, regeneration, resolution).
  • PCEC subpopulations were analyzed for differential gene expression and signaling pathway alterations.

Main Results

  • Lung injury induced transcriptomic shifts in three PCEC subpopulations, associated with pro-angiogenic signaling and Lrg1 expression.
  • The resolution of fibrosis differed significantly between young and aged mice, with altered PCEC marker expression in aged individuals.
  • Resolution-associated markers found in aged PCEC were also detected in PCEC from patients with idiopathic pulmonary fibrosis.
  • Aging altered PCEC transcriptomes, exhibiting pro-fibrotic and pro-inflammatory characteristics.

Conclusions

  • Age-associated alterations in specific PCEC subpopulations may hinder lung progenitor cell differentiation.
  • These PCEC changes likely contribute to the persistent fibrotic processes observed in aging lungs and human fibrotic lung diseases.
  • Targeting age-related PCEC dysfunction presents a potential therapeutic strategy for fibrotic lung diseases.